2022年8月2日,

描述:糖尿病是一種慢性病,需要不斷的自我管理。數字糖尿病管理解決方案支持糖尿病患者需要采用生活方式幹預或藥物調整響應葡萄糖監測數據。數字糖尿病管理解決方案包括臨床項目、服務和集成技術來支持人們的需求在整個頻譜的護理。技術進步在數字糖尿病管理市場燃料需求數字醫療技術,尤其是數字和醫療應用程序(應用程序),快速發展幫助人們管理自己的糖尿病狀態。例如,2022年3月,Glooko inc .)收購DIABNEXT擴大糖尿病在法國發行。DIABNEXT移動應用補充Glooko的產品組合和追蹤糖尿病數據。2022年2月,作秀的成分與Diabeloop公司進入一個協議。根據協議,公司將整合治療人工智能自動化的治療1型糖尿病。越來越多的人意識到關於糖尿病自我管理解決方案驅動市場增長的糖尿病自我管理包括糖尿病教育、健康飲食、運動、藥物、設備使用、監控,並使用我們的數據來調整行為和藥物劑量。提高意識,一些球員和不同國家的政府宣傳活動/培訓。 For instance, Diabetes Self-Management Training (DSMT) Certification Diabetes Self-Management Education and Support (DSMES) services World Diabetes Day (WDD) is the world's largest diabetes awareness campaign Role of mHealth in Diabetes Management Boosts the Digital Diabetes Management Market Demand Diabetes is the most popular chronic clinical condition targeted by mHealth, followed by depression and asthma. Mobile health (mHealth) tools have enhanced diabetes management and prevention and are likely to play an increasing role with the growth of smartphone ownership and medical device innovations. For instance, In May 2021, F. Hoffmann-la Roche teamed up with Ellerca Health to launch Accu-Chek + 360Care, integrating Roche’s Accu-Chek Guide blood glucose meter, customized home delivery of testing strips, and Ellerca’s self-management digital program, 360Care Key Market Challenges: Digital Diabetes Management Market Reimbursement issues in developing countries, high costs associated with the devices, rising concerns regarding data security, and preference for traditional diabetes management over digital diabetes management are some of the key factors that are likely to hamper the growth of the market. North America Expected to Continue Holding Major Share in the Digital Diabetes Management Market North America currently holds a major share in the global digital diabetes management market. North America is expected to continue to hold a major share in the coming years due to the growing prevalence of diabetes and the growing adoption of technologically advanced products, in the region. Competitive Landscape Analysis: Digital Diabetes Management Market Some of the key players operating in the global digital diabetes management market are Medtronic Plc, Abbott, F.Hoffmann-LA Roche Ltd, Senseonics, and Insulet Corporation, among others. Organic and Inorganic Growth Strategies Adopted by Industry Players to Establish Their Foothold in the Digital Diabetes Management Market Players operating in the digital diabetes management market are adopting organic and inorganic growth strategies such as collaborations, acquisitions, and new product launches to garner market share. For instance, In April 2022, Dexcom launch Dexcom ONE Continuous Glucose Monitoring System. The Dexcom ONE system is an easy-to-use real-time CGM (rt-CGM) that more affordable and accessible for people with diabetes in the UK. In April 2022, Abbott entered into a partnership with CamDiab and Ypsomed. Under the terms of the partnership, the three companies plan to develop and commercialize an integrated automated insulin delivery (AID) system. Explore Detailed Research Insights on Digital Diabetes Management Market @ https://meditechinsights.com/digital-diabetes-management-market/ About Medi-Tech Insights: Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services. Contact Us: